NBC Evening News for Thursday, Apr 30, 1981
View other clips in this broadcast →
Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws. For any such use, please visit NBC NEWS Archives XPRESS.
(Studio) Results of 1st government-controlled test of Laetrile on humans suffering from cancer reported; FDA's efforts to ban Laetrile, also known as Amygdalin recalled.
REPORTER: John Chancellor
(No location given) Findings of National Cancer Institute's tests examined; films shown. [Mayo Clinic spokesperson Dr. Charles MOERTEL - notes lack of effect of Laetrile on cancer.] Impact of political pressure in support of Laetrile noted; Tijuana's incrd. popularity as treatment center for cancer victims noted calling for bus tours from Los Angeles clinics. [Hoxsey Clinic spokesperson Dr. Yolanda FRIEDAY, Cydel Clinic spokesperson Dr. Frank SULLIVAN, Gerson Clinic spokesperson Charlotte Gerson STRAUSS - promote their clinics.] Various therapies available, include Laetrile, discussed; patient Jean Patton's situation cited as example [Jean PATTON and husband - discuss her reaction to chemotherapy.] Patients from Tijuana clinics said arriving at Chula Vista, California, hospital near death. [Hospital spokesperson Veronica THERIAK - comments on patient's reaction to Laetrile clinics.]
REPORTER: Robert Bazell
Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.
Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:
If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.